Female Contraceptive Devices (Vaginal Ring)

Subscribe to Selected New Research on Female Contraceptive Devices

147 relevant articles (14 outcomes, 21 trials/studies) found for this Therapy

Description: Contraceptive devices used by females.

Also Known As:

Vaginal Ring; Cervical Cap; Vaginal Rings; Contraceptive Devices, Female; Coiled Spring; Vaginal Diaphragm; Vaginal Shield; Vaginal Sponge; Cap, Cervical; Caps, Cervical; Cervical Caps; Coiled Springs; Contraceptive Device, Female; Device, Female Contraceptive; Devices, Female Contraceptive; Diaphragm, Vaginal; Diaphragms, Vaginal; Female Contraceptive Device; Ring, Vaginal; Rings, Vaginal; Shield, Vaginal; Shields, Vaginal; Sponge, Vaginal; Sponges, Vaginal; Spring, Coiled; Springs, Coiled; Vaginal Diaphragms; Vaginal Shields; Vaginal Sponges

Relationship Network

Therapy Context: Research Results

Equipment and Supplies

Contraceptive Devices: 79

Female Contraceptive Devices: 147

Intrauterine Devices: 2984

Female Condoms: 133

Experts

1.	Tsong, Yun Yen: 2 articles (07/2005 - 07/2005)
2.	Gale, Judi: 2 articles (07/2005 - 07/2005)
3.	Brache, Vivian: 2 articles (07/2005 - 07/2005)
4.	Weisberg, Edith: 2 articles (07/2005 - 07/2005)
5.	Mishell, Daniel R: 2 articles (07/2005 - 07/2005)
6.	Apter, Dan: 2 articles (07/2005 - 07/2005)
7.	Alvarez, Francisco: 2 articles (07/2005 - 07/2005)
8.	Massai, Rebeca: 2 articles (07/2005 - 07/2005)
9.	Sivin, Irving: 2 articles (07/2005 - 07/2005)
10.	Fraser, Ian S: 2 articles (07/2005 - 07/2005)

Related Diseases

1.	Atrophy 01/01/1997 - "CONCLUSION: data from this change-over study confirm efficacy and safety of both the vaginal ring and cream in the treatment of postmenopausal women with urogenital atrophy symptoms and signs" 02/01/2003 - "Menopausal vaginal rings can be designed to allow very low dose local delivery of oestrogen to the vagina for the large percentage of postmenopausal women experiencing urogenital atrophy, or can be modified to deliver much higher doses sufficient for systemic oestrogen replacement therapy, with or without simultaneous progestogen release" 04/01/1996 - "PARTICIPANTS AND INTERVENTIONS: One hundred and ninety-four postmenopausal women with symptoms and signs of urogenital atrophy were randomised on a 2:1 basis to 12 weeks of treatment with an oestrogen vaginal ring versus an oestrogen cream" 12/01/1995 - "A multicentre Australian trial of low dose estradiol therapy for symptoms of vaginal atrophy using a vaginal ring as delivery system." 01/01/1999 - "Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study" Order ALL the reference details at left...
2.	Sexually Transmitted Diseases (Sexually Transmitted Disease) 09/01/2002 - "The urgent need for female-controlled contraceptive methods with the potential to protect against sexually transmitted diseases makes this low-dose spermicidal vaginal sponge an effective and safe alternative." 06/17/1997 - "Vaginal sponges offer women control over protection against both pregnancy and sexually transmitted diseases (STDs), including HIV" 09/01/2000 - "The hierarchy message promoted male and female condoms, the diaphragm and cervical cap, spermicides, and withdrawal, in descending order of effectiveness against sexually transmitted diseases" 01/01/1998 - "In descending order of effectiveness, the following methods can protect against the transmission of HIV and STDs: abstinence, nonpenetrative sex, long-term mutual monogamy with HIV testing, male condom with spermicide, male condom, female condom, diaphragm and cervical cap, and vaginal spermicide alone" 03/01/1996 - "Diaphragms and cervical caps are effective contraceptive shields, but are less reliable against pregnancy and sexually transmitted diseases than the male condom" Order ALL the reference details at left...
3.	Inguinal Hernia (Direct Inguinal Hernia) 02/01/2008 - "CLINICAL RELEVANCE: Laparoscopic suture closure of the internal inguinal and vaginal rings provides safe and effective repair of inguinal hernia in horses." 08/01/2007 - "OBJECTIVE: To evaluate the efficacy of a laparoscopic peritoneal flap hernioplasty (PFH) to close anatomically the vaginal ring and to evaluate its protective effect in horses with a history of strangulated inguinal hernia (SIH) against future herniation" 02/01/2008 - "OBJECTIVE: To report a technique for repair or prevention of inguinal hernia in horses using intracorporeal suture closure of the internal inguinal and vaginal rings" Order ALL the reference details at left...
4.	Hemorrhage 07/01/2005 - "CONCLUSION: Our study shows advantageous bleeding patterns for subjects using the contraceptive vaginal ring" 03/01/2007 - "Among these 75 women, dissatisfaction with bleeding patterns was not a frequent reason given for discontinuation of the contraceptive vaginal ring." 03/01/2007 - "Bleeding patterns of women using extended regimens of the contraceptive vaginal ring." 09/01/2005 - "OBJECTIVE: To compare the bleeding patterns and tolerability of 3 different extended ring regimens with those of the standard 28-day cycle with 21 days of contraceptive vaginal ring use followed by 7 ring-free days" 02/01/2005 - "The incidence of intended bleeding was significantly higher over all cycles with vaginal ring (58.8-72.8%) than with the COC (43.4-57.9%)" Order ALL the reference details at left...
5.	Infertility (Sterility) 09/01/1993 - "Therefore, in order to determine the efficacy of cryopreserved semen, 43 consecutive women with absolute male factor infertility (single women or wives of azoospermic men) were inseminated with cryopreserved spermatozoa using cervical caps" 08/01/1991 - "Intrauterine insemination by itself for multiple and/or severe infertility factors had no benefit over cervical cap with whole ejaculate or coitus in this study" 08/01/1991 - "The PRs for IUI and cervical cap with whole ejaculate or coitus were similar and low, suggesting that IUI by itself has limited, if any, utility in enhancing PRs in this type of infertility population" 01/01/1987 - "It is currently completing studies on, the post-abortion insertion of IUD, and the acceptability of vaginal rings, and is studying the incidence of sexually transmitted diseases on sterility." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Estradiol (Estrace)
2.	Tablets
3.	Nonoxynol (Nonoxynol 9)
4.	Levonorgestrel (Plan B)
5.	Estrogens (Estrogen)
6.	Vaginal Creams, Foams, and Jellies (Vaginal Tablet)
7.	Raloxifene (Evista)
8.	Ethinyl Estradiol (Estinyl)
9.	ST 1435
10.	Contraceptive Agents (Contraceptives)

Related Therapies and Procedures

1.	Pessaries
2.	Female Contraceptive Devices (Vaginal Ring)
3.	Contraception (Birth Control)
4.	Sutures (Suture)
5.	Intrauterine Devices (Intrauterine Device)

Best Treatments:
Research Summary Report
on Atrophy

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 341 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>